“The vaccine, developed in the United States, received this first favorable unanimous opinion, which represents an advance in the approval process necessary to meet the quality, safety and efficacy requirements, essential when considering a product. The next step is to authorization for emergency use, “reported Cofepris.
As detailed, through a statement, the CMN and theSEPB are auxiliary consultation bodies and are part of the Cofepris, which issue non-binding opinions on medicines and other health supplies, so this step does not yet represent an authorization for use.
Moderna is an American biotechnology and pharmaceutical company that researches and develops drugs. Its coronavirus vaccine is also known as mRNA-1273.
Marcelo Ebard, Secretary of Foreign Relations and Hugo López-Gatell, Undersecretary of Health, celebrated the step that this represents, prior to the authorization for emergency use of the vaccine.
“This will allow us to use the doses that the United States government will send to our country and thus accelerate the National Vaccination Plan against # COVID19,” López-Gatell posted on Twitter.
While the chancellor published, “very good news, we can now bring it to Mexico.”
It should be remembered that on August 10, Ebrard announced that the United States agreed to send a total of 8 million vaccines against COVID-19 from Moderna and AstraZeneca to Mexico, this after President Andrés Manuel López Obrador made a phone call with US Vice President Kamala Harris.
“Yesterday there was a call from President López Obrador with the US Vice President, Kamala Harris (…) it was commented yesterday that Mexico will receive, will send the US to Mexico, 3 and a half million doses of Moderna’s vaccine, that has already been or is about to be validated by Cofepris, and 5 million doses of the AstraZeneca vaccine ”, said the secretary.
Since last July 17, the Foreign Minister had announced that “very soon” the Moderna vaccine would be approved in Mexico for emergency use, but this has not happened, although there is already a first step.
Effectiveness of Moderna’s vaccine
Moderna’s vaccine requires two doses of application, intramuscularly, with an interval of 28 days between the first and the second, and if necessary, according to the pharmacist’s indication, the term of application of the second dose can be extended by up to 42 days.
According to the World Health Organization (WHO), Moderna’s vaccine contains messenger RNA and has an efficacy of 94.1%.
In addition, aAlthough the multidose vials included in the packages contain a suspension that must be stored at a temperature between –25 ° C and –15 ° C, they can be kept refrigerated at a temperature between 2 ° C and 8 ° C for 30 days. before taking the first dose of them.
Thanks to this characteristic, in many cases it is not necessary to have equipment to maintain the extreme cold chain.
– .
